Cargando…
Reply to Rheumatologists’ perspective on coronavirus disease 19: is heparin the dark horse for COVID-19?
Autores principales: | Ahmed, Sakir, Anirvan, Prajna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer London
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211055/ https://www.ncbi.nlm.nih.gov/pubmed/32388748 http://dx.doi.org/10.1007/s10067-020-05145-w |
Ejemplares similares
-
Targeting the immunology of coronavirus disease-19: synchronization creates symphony
por: Ahmed, Sakir, et al.
Publicado: (2020) -
Type and dose of heparin in Covid‐19: Reply
por: Thachil, Jecko, et al.
Publicado: (2020) -
Reply to: Cadaverless anatomy: Darkness in the times of pandemic Covid-19
por: Murlimanju, B.V., et al.
Publicado: (2020) -
Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets
por: Misra, Durga Prasanna, et al.
Publicado: (2020) -
Reply to “Coronavirus Disease 19 (COVID-19): Implications for Clinical Dental Care”
por: Ather, Amber, et al.
Publicado: (2020)